In both animal and human studies, increased CD36 expression in metabolically active tissue has been implicated in regulation of fatty acid metabolism and enhancement of fatty acid internalization and lipid accumulation, thus leading to insulin resistance [45, 46]. The gene discussed is CD36; the disease is Insulin resistance.